Events

Videos

Podcasts

Articles

Clinical

® Clinical Focus page includes a listing of all specialities covered across  OncLive.com, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, hematologic malignancies, and gynecologic cancers. Each individual specialty page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research.


Lymph Node Dissection in Bladder Cancer

Introduction: Neoadjuvant Chemotherapy in Bladder Cancer

Alan M. Miller, MD, PhD, Director of the Baylor Charles A. Sammons Cancer Center and Chief of Oncology for the Baylor Health Care System, discusses immunotherapy for cancer treatment.

Dr. Alan Miller on Immunotherapy for Cancer Treatment

Genetic Testing in RCC

Immune Checkpoint Inhibition in RCC

Second-Line Cabozantinib in mRCC

Second-Line Treatments in RCC

Investigational Approaches in RCC

VEGF Versus mTOR in Non-Clear Cell RCC

Sunitinib Versus Pazopanib in Renal Cell Carcinoma

Managing Untreated Metastatic Renal Cell Carcinoma

Role of Radiation Therapy in Renal Cell Carcinoma

Introduction: Surgical Approaches in mRCC

A trial comparing frontline pembrolizumab with ipilimumab for the treatment of advanced melanoma has met its progression-free survival and overall survival endpoints

Frontline Pembrolizumab Bests Ipilimumab in Phase III Melanoma Trial

OncLive interviewed Jason J. Luke, MD, who discussed the clinical implications of immunotherapies in melanoma, with optimal sequencing and combinations emerging as the most pressing questions that researchers are seeking to answer in ongoing clinical trials.

Anti-PD-1 Therapy Poised to Take the Next Step in Melanoma

Elizabeth A. Mittendorf, MD, PhD, differentiates the main types of immunotherapy, highlights some of the most interesting results in breast cancer trials, and discusses why different types of immunotherapy might be appropriate for different types of breast tumors at various stages of development. 

Immuno-Oncology | Specialty